Lemaitre Vascular (LMAT) Cash & Current Investments (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Cash & Current Investments data on file, last reported at $367.2 million in Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $367.2 million, up 21.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $367.2 million (up 21.38% YoY), and the FY2025 annual result was $359.1 million, up 19.82% from the prior year.
• Cash & Current Investments climbed to $367.2 million in Q1 2026 per LMAT's latest filing, from $359.1 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $367.2 million in Q1 2026 and troughed at $70.9 million in Q1 2022.
• A 5-year average of $177.6 million and a median of $108.3 million in 2024 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2023: Cash & Current Investments soared 247.87% in 2022, then gained 14.28% in 2023.
• A 5-year view of Cash & Current Investments shows it stood at $82.7 million in 2022, then climbed by 27.07% to $105.1 million in 2023, then soared by 185.25% to $299.7 million in 2024, then grew by 19.82% to $359.1 million in 2025, then gained by 2.26% to $367.2 million in 2026.
• Business Quant data shows LMAT's Cash & Current Investments at $367.2 million in Q1 2026, $359.1 million in Q4 2025, and $343.1 million in Q3 2025.